【Countries

Supporting Medical Technology in Developing Countries】】

Makoto Tojo
Tokyo Medical and Dental University【International contribution based on my own
experience 】
As a Biomedical laboratory scientist, I’d like tocontribute to the spreading and developing oflaboratory technology in areas where healthcare
is yet advanced. The first reason is based on myexperience in Jakarta, where I lived when I wasin high school. There is severe wealth inequality
in Indonesia. Because health care in Indonesia isundeveloped, wealthy people visit neighboring
countries like Malaysia and Singapore for
medical treatment and health checkups. In
addition, the latest medical facilities areconcentrated in the capital city, Jakarta, andequal medical care cannot be provided. Recently
in Indonesia lifestyle diseases such as diabetes
and cardiovascular diseases are increasing, inaddition to infectious diseases. Therefore, theimprovement of clinical examination techniquesand education for the early detection of diseases
should also be emphasized. The second reason is
my experience of interacting with Laotian
students in the international exchange program"Virtual Café” held at TMDU. I heard that in
Laos, pathological examinations are notwidespread, and enough types of examinationequipment and kits are not provided. In addition,
I learned that examination and treatment are
not conducted equally in rural areas due toinadequate infrastructure construction. For
these reasons, I would like to strive to educate
and improve laboratory techniques in developing
countries.
【Issues to consider when providing support】
However, there are some problems relating to
the education of medical technology. The first is
the difference in national characters. We are
required to seek the best way to educate staff. So,
they can understand how accurate results areimportant to help patients in a way specialized
for local people. For example, in Indonesia, I
have felt that the public health perspective inpoor areas is not the same as in Japan. When I
volunteered to teach English to children in rural
areas, I saw many children throwing garbage ofstacks away into waterways. Therefore, for thedevelopment of medical technology, it isimportant to broaden the idea of public health,such as hygiene management, environmental
hygiene, and infection control. The second
problem is that the environments differ greatly
between urban and rural areas, anddevelopment in urban areas alone will not leadto improvements in medical technology in rural
areas. Moreover, it is necessary not only to
spread clinical testing technology but also tosecure infrastructure and manage equipment sothat equipment and reagents can be purchased.
【Prospects for the future and what we can do 】
Continuing education without understanding
differences in national character will not lead tofuture development. It is necessary to improve
the situation by thinking together with the local
staff. In Indonesia, there are many islands where
people have different languages, cultures, andadministrations. So, it is crucial to understandthe backgrounds and to expand the range ofknowledge in different fields such as politicalscience and economics. To contribute todeveloping countries, it is important to find myown field of expertise, refine my skills andaccumulate knowledge as a Biomedicallaboratory scientist. Even if I don't go to othercountries, I can make efforts for international
cooperation in Japan. When I communicatedwith Taiwanese students at the "Virtual Café”, I
heard that they want to study Japanesetechnology as exchange students. I believe that I
can help accept overseas trainees anddisseminate the technology while working as a
Biomedical laboratory scientist. As a sophomore,
what I can do is use English in a practical way.
Also, it’s important to understand the current
situation of the country through communication.
For future medical development, it is necessary
to collaborate with experts in other fields.
Therefore, I’m willing to interact with people invarious situations and broaden my perspectives.
Contact information
Student name: Makoto Tojo
Teacher name: Ryunosuke Ohkawa
Tokyo Medical and Dental University
Tel: +81-3-5803-5374
Fax :+81-3-5803-0166
Teachers E-mail: ohkawa.alc@tmd.ac.jp

【発展途上国での検査技術の支援のために】

東條真琴
東京医科歯科大学【自身の経験を生かした国際的な貢献】
私は、臨床検査技師として、医療が未発達の地域における検査技術の普及および発展に貢献したいと考えている。その理由は二つある。一つ目は高校のころ住んでいたジャカルタでの経験である。イ
ンドネシアは貧富の差が激しく、裕福な人たちイ
ンドネシアの医療が不十分なため、マレーシアやシンガポールへ治療や検査を受けに行く。また、最新医療設備も首都のジャカルタに集中してしまい、
平等な医療を提供することができていない現状がある。インドネシアでは、発展途上国に見られる、
感染性疾患だけではなく、経済発展に伴った糖尿病や循環器疾患などの非感染性疾患の患者も増加傾向にある。そのため、臨床検査の技術の向上および疾患の早期発見のための教育も重要視されている。また、東京医科歯科大学医学部保健衛生学科検査技術学専攻の学生向けに開催された国際交流プ
ログラム「Virtual Café」でラオスの学生と交流した際の経験が二つ目の理由である。ラオスでは、病理検査の普及が乏しく、検査機器やキットも種類が乏しいという話を聞いた。また、地方ではインフラ整備も十分でないため、平等に検査および治療が行われているわけではない現状を知った。これらの理由から、発展途上国における検査技術の教育および向上に努めたいと考えている。
【支援をする上で考慮すべき問題点】
支援する上での問題点の一つ目は、国民性の違いである。いかに正確性のある結果が患者を助けるために重要なのかを理解してもらえるよう現地の方に適した教育を行う必要がある。例えば、インドネシアでは貧困地域における公衆衛生的な観点が乏しいと感じる経験が何度かあった。貧困地域の子供たちに英語を教えるボランティアをした際に、スナック菓子のゴミを当たり前のように水路に捨てていた様子を見た際に、環境衛生に対する考えの違いを認識した。したがって、医療の発展のためには、衛生管理、環境衛生、感染対策など公衆衛生の考えを普及することも重要となる。発展途
上国は問題が一つではないため、検査技術の発展のためには根気強く、できるところから少しずつ行動することが求められる。二つ目の問題点としては、発展途上国でも都市部と地方で環境が大きく違い、都市部だけの発展では、地方の検査技術の向上には繋がらない。ラオスでの検査機器やキット自体の獲得が難しいという話から、臨床検査技術の普及だけではなく、機器や試薬を購入できるような運営、インフラの確保などが必要となると考える。

【将来への展望と今できること】
国民性の違いを意識せず、教育を続けることは、
将来的な発展に繋がらない。先進国の立場から教育をするのではなく、現地の人の価値観を意識したうえで、現地の人と一緒に考えながら改善していく必要がある。国の中でも地域によって言語、文化、行政が大きく異なる場合もあるため、それらの背景の理解も必要となる。そのため、医学的知識だ
けではなく、政治学、経済学などの他分野の知識の幅も広げていく必要がある。自分自身の専門分野を見つけ、臨床検査技師として実務経験を積み、技術を磨き、知識を蓄えることが最優先である。また、日本国内だけではなく、他の先進国における技術の研究を学ぶことも大切であり、常に様々な研究や考え方にアンテナを張っていきたいと考える。
そして、他の国に行かなくても、国内で国際活動をすることはできる。「Virtual Café」で台湾の学生と交流した際に、日本で留学生として日本の技術を学びたい、という話を聞いた。そのため、臨床検査技師として働く中でも海外の研修生の受け入れに協力し、技術の普及を行うことができると考える。その上では、英語の実践的な学びが必要となる。
学部 2 年生の私が現在できることは、海外研修プ
ロジェクトなどで英語を実用できる環境に身を置くことであると考える。また、交流などを通じて、その国の現状を理解し、常に自分は何ができるのかを考えていくことが重要である。今後の発展のためには、他分野の専門家と連携することが求められる。そのため、学生の内から、様々な立場の人と交流をし、価値観を広げていきたいと考える。
連絡先： 210029ts@tmd.ac.jp〒 113-0034
東京医科歯科大学
東京都文京区湯島 1 丁目 5 番 45 号
電話：03-5803-5374
Fax :03-5803-0166
学生氏名：東條真琴 (トウジョウ マコト)
教員氏名：大川龍之介
教員電子メール：ohkawa.alc@tmd.ac.jp

【What biomedical laboratory scientists can do for achieving the goals of SDGs】
Konatsu Imanaka, Yuki Omoto, Natsuki Okamoto, Kanako Kai
Department of Medical Technology and Sciences, Faculty of Health Sciences,
Kyoto Tachibana University【SDGs and biomedical laboratory scientists】

In order for BLSs to contribute to SDGs, it is also

We had an active discussion on "what we can doimportant to improve existing laboratory methods. Forinternationally as biomedical laboratory scientists

example, it has been reported that the use of recycled(BLSs)”. Then, we concluded that we would like tosolvents

contribute to solving

international problems. In

equivalent to the conventional performance.4) Since

particular, we focused on Sustainable Development

such studies would lead to a significant reduction in theGoals (SDGs), which aim to realize a sustainable world

disposal of various solvents, it is desirable to improveby 2030. SDGs set 17 goals,1) and various efforts areexisting methods in other fields of biomedical laboratory

being made around the world to achieve them. The Goal

science. In the future, we’d like to contribute to SDGs

12 of SDGs, "Ensure sustainable consumption and

by developing eco-friendly laboratory methods andproduction patterns", promotes development of eco-reagent recycling methods.

friendly products and reduction ofwastes.2)

In thisinpapanicolaou

staining

wasalmost【Conclusion】

manuscript, we describe the survey results about

We concluded that BLSs should reduce medical

environmental problems caused by medical wastes andwastes and revise existing laboratory methods from the

how to improve them. In addition, we discuss how BLSs

perspective of environmental protection. To achieve

can contribute to achieving the goals of SDGs.

these aims, we would like to propose the following【What is eco-friendly laboratory science】

future improvements.

Medical wastes include infectious and non-infectious①

Reducing plastic use in medical products

wastes, both of which are commonly found in biomedical②

Setting recycling boxes for discarding of non-laboratories. Generally, infectious wastes are speciallydiscarded as industrial wastes, while non-infectious

infectious wastes in biomedical laboratories③

Developing the eco-friendly methods of reagent

wastes are disposed as general wastes. We thought itusage and technology in biomedical laboratory

particularly desirable to reduce the use and disposal ofscience

non-infectious wastes.

By addressing these three issues, we would like to

Microplastics (MP) are examples of the negative

contribute to achieving the goals of the SDGs.

environmental impact of non-infectious wastes. MP are(References)

plastics with a diameter of 5 mm or less, which cause

1) Ministry of Foreign Affairs, JAPAN SDGs Actio

marinepollution.

Inaddition,fish

sometimes

accidentally take MP into their body, and humans aren Platform HP, (https://www.mofa.go.jp/policy/oda/sdgs/index.html) (1/10/2023, access)indirectly exposed to MP by eating them. It has been2) United Nations, Department of Economic and S

pointed out that endocrine disruptors in MP may inhibit

ocial Affairs HP (https://sdgs.un.org/goals/goal12)

the biosynthesis of adhesion proteins in mucosal cells.3)
Thus, environmental pollution disturbs not only plants(1/10/2023, access)3) Otsuka Y, et al：Current Status and Issues in M

and animals but also our health. This is a particularly

icroplastic Pollution Research, Journal of Enviro

important issue for achieving Goal 12.

nmental Studies Journal of Japan Society on

To solve the problem of medical wastes including MP,

Water Environment 44(2):35-42, 2021.

we should reduce the wastes themselves. At present,4) Nohata M et al.: Environmental conservation wimost disposable instruments used in biomedical

th recycling as the main axis Papanicolaou stailaboratories are wrapped in plastics, and their disposal

ning, clinical examination 45(3):327-400, 2002.

leads to generation of MP. As a countermeasure, it’sContact information
Student name: Konatsu Imanaka
Teacher name: Kohki Okada
Kyoto Tachibana University, 34 Yamada-cho,Oyake Yamashina-ku, Kyoto city, Japaneffective to substitute paper packaging for these
instruments. Another good approach is setting up
recycling boxes in biomedical laboratories. This will not
only to enable the recycling of wastes, but also to
improve the awareness of BLSs toward environmental
protection. In the future, we would like to take an activerole in such efforts in biomedical laboratories andcontribute to the international communities.

Tel: +81-75-571-1111
Fax :+81-75-574-4122
Teachers E-mail: okada-ko@tachibana-u.ac.jp

【SDGs の目標達成に向けて臨床検査技師ができること】
今中小夏、大本有喜、岡本渚月、甲斐かなこ
京都橘大学 健康科学部 臨床検査学科【SDGs と臨床検査技師】
我々は，「自身が臨床検査技師として国際的に行いたいの取り組みを積極的に担い, 国際社会に貢献したいと考える。

こと」について話し合い, 結果, 国際的な課題の解決に貢

臨床検査技師による SDGs への貢献には, 既存の検査献したいという意見に収束した。国際的な課題の中でも,法を見直す姿勢も重要である。例えば, 病理検査の染色に

近年話題の SDGs(持続可能な開発目標)に関する意見が多使用する薬品には，毒性が強いものや環境に有害なものがくみられた。
SDGs とは, 2030 年までの達成を目標とした,ある。リサイクル溶媒を用いたパパニコロウ染色では，従持続可能でよりよい世界を目指す国際目標である。環境保来法と比べ細胞質の染色性および透過性がやや弱いもの全やヒトの QOL 向上を目的とした 17 個の目標が設定さの, 染色時間の延長によりほとんど差がなく使用できたれており 1)，これらの達成に向け世界中で様々な取り組みとの報告がある 4)。各種溶剤の購入費・使用量・廃棄量のがなされている。SDGs の各目標の中でも Goal 12「責任大幅な削減に繋がる結果が示されたことで, 臨床検査のある消費と生産」では，環境に配慮した製品開発や, 廃棄

他分野でもこのような既存法の見直しや改良が望まれる。

物の発生を減らすことが掲げられている 2)。例として，生そのためには将来, 環境に配慮した検査方法・製品の開発

分解性プラスチックを用いた製品の開発や, 使い捨てプが重要と考えた。我々も将来, 従来法の代替となる環境に

ラスチック製品の利用を減らすことなどが挙げられる。臨配慮した検査法の開発や, 検査結果に影響がない範囲で床検査室においても，感染性・非感染性問わず大量の医療の試薬類のリサイクル手法の考案に尽力し, SDGs 達成に廃棄物が出る。本稿において我々は，医療廃棄物がもたら貢献することを目指したい。

す環境問題と, その改善方法について調査した結果を記【結論】すと共に, SDGs の達成に向けて臨床検査技師がどのよう我々が住む地球を守るために臨床検査技師としてできな貢献ができるのかを考察する。

ることは，医療廃棄物の削減に貢献することに加え, 環境【環境に配慮した臨床検査とは】保護の観点から既存の臨床検査法を見直すことであると医療廃棄物には感染性廃棄物と非感染性廃棄物があり,結論づけた。そのために将来, 私達が取り組みたい具体的

いずれも臨床検査室にて盛んに見られるものである。感染な事項は以下である。

性廃棄物は産業廃棄物として特殊処理されるが，非感染性① 医療用品におけるプラスチック使用の削減

廃棄物は一般ごみと同様に処理される。我々は, 特に非感

② 非感染性ごみ用の検査室内リサイクル BOX の設置

染性廃棄物について, 使用量や廃棄量の削減が望ましい③ 環境に配慮した試薬利用法や検査法の考案と考えた。

これら 3 項目を行うことで, 国際的な課題である SDGs

非感染性廃棄物による環境への悪影響の例として, マの目標達成に寄与していきたい。

イクロプラスチック(MP)がある。MP とは直径 5mm 以下(参考文献・URL)のプラスチックを指しており, 海洋汚染の原因の一つで

1) 外 務 省 , JAPAN SDGs Action Platform HP,ある。さらに, 魚が MP を誤って体内に取り込むことで,食物連鎖を介して間接的にヒトの体内に曝露されること(https://www.mofa.go.jp/policy/oda/sdgs/index.html)(2023 年 1 月 10 日アクセス)もある。それによって，MP 添加物の内分泌攪乱物質が粘2) United Nations, Department of Economic and Social

膜細胞の接着タンパク質の生合成を阻害する可能性が指
環境汚染はそこに生息する

Affairs HP (https://sdgs.un.org/goals/goal12) (2023
年 1 月 10 日アクセス)

動植物のみならず, やがてヒトにも悪影響を及ぼすので

3) 日本環境化学会：2019.$7 化学物質が免疫機構に異常ある。このことは Goal 12「責任ある消費と生産」の達成を引き起こす - 免疫かく乱とアレルギー疾患，地球にあたり, 特に重要な課題と考える。

をめぐる不都合な物質：pp190-213，講談社，2019.

摘されている 3)。このように,

MP を含む医療廃棄物の問題を解決するためには，廃棄

4) 野畑真奈美 他：リサイクルを主軸にした環境保全型

物そのものを減らせば良い。現状, 臨床検査に使用するデパパニコロウ染色，臨床検査 45(3):327-400, 2002.

ィスポーサブルの器具の多くはプラスチックで包装されており, これらの大量廃棄は MP 発生に繋がる。対策として, これらをできる限り紙の包装で代用することが有効と考える。また，臨床検査室にリサイクル BOX を設置す
るのも, 優れた取り組みといえる。これは, 単に廃棄物のリサイクルができるだけでなく，臨床検査技師を含めた医療従事者の環境保護への意識の向上に繋がると推測される。我々は将来, このような臨床検査室における環境保護

連絡先： 京都橘大学健康科学部臨床検査学科〒 607 - 8175
電話：075 – 574 - 4486
Fax : 075 – 574 - 4122
学生氏名：今中小夏(イマナカ コナツ)
教員氏名：岡田光貴(オカダ コウキ)
教員電子メール：okada-ko@tachibana-u.ac.jp

【Toward a country where foreign residents can receive home medical care】
Mayu Suzuki
Kobe Tokiwa University【Introduction】
In recent years, the number of foreign residents inJapan has been increasing. It is suggested that the
number of foreign residents is likely to continue
increasing. The biggest problem foreigners have in
hospitals is the language problem. The second
problem is the issue of hospital selection. Foreign
language support is also the most common issue forhospitals. In this situation, I think that this will besolved if foreigners can receive home medical care.
Furthermore, I would like to enhance the quality ofhome medical care through the participation of
Biomedical Laboratory Scientists (BLS) and theintroduction of remote access. This paper will discussthese in detail.
【The participation of BLS in home health care】
Currently, participation of BLS in home health careis low. Doctors and nurses are at the heart of homehealth care. I think that the participation of BLS inthis process will help us to provide better medicalcare. BLS are able to synthesize examination data
and also fully understand the data of each patient. In
addition, BLS are also able to provide accurate test
results from specimen collection and processing, suchas blood sampling. Therefore, BLS are considered
suitable personnel for home health care. And I
believe that BLS should participate more than they
do now in the field of home health care.
【Home health care using remote】
The Coronavirus pandemic has changed the way ofwork. The most common tool used in during theCoronavirus pandemic is ICT remote. I think thatworking remotely with ICT can be useful for homehealth care to develop the potential of personalizedcare for patients. The telework allows BLS to closelycollaborate with physicians and other healthcare
professionals in the hospital with accurate test
results provided by them. I think that the remotesystem will enable various medical professionals towork as a team to provide home medical care topatients.
【Language problem】
Preparation of language support is possible by using
application information made by the patient. This
allows us to facilitate testing and explanation. For

example, we can prepare how to speak and explain in
a foreign language and provide clear explanations
with illustrations. In addition, knowing culturaldifferences will allow medical care to be tailored to
the needs of the patient. Furthermore, I think that
foreign patients will be able to receive medical carewith peace of mind. Knowing the language used andpreparing in advance is difficult for outpatient care.
For this reason, the challenge of addressing language
issues in hospitals still remains unresolved.
Therefore, home health care would provide morecomprehensive care, compared with outpatient care.
【The problem of hospital selection】
I think that accepting foreign residents for home
medical care will solve not only the language problem
but also the problem of hospital selection. In my
proposal, the local government contacted by foreign
residents would request the hospital to send out a
BLS to their residence. The BLS then uses the test
results obtained at their home in order to give theright diagnosis and effective treatment. This systemof home healthcare will release foreign patients fromworries about which hospital they themselves should
visit. Therefore, I think that the problem of choosing
hospitals can be solved when foreigners receive home
medical care.
【Conclusion】
I would like to provide fulfilling medical care by BLS
participating in-home medical care more frequently
than they do now, and by readily accepting foreign
residents. I would also like to use ICT and othermodern technologies to improve the efficiency of
medical care in the home. Therefore, in the future, I
would like to make health care better and more
useful for both providers and recipients.
Contact information
Student name: Mayu Suzuki
Teacher name: Hideo Sakamoto
Kobe Tokiwa University
2-6-2 Otani, Nagata Kobe,
Hyogo 653-0838, Japan
Tel: +81-78-611-1821
Fax :+81-78-643-4361
Teachers E-mail: h-sakamoto@kobe-tokiwa.ac.jp

【外国人住民も在宅医療が受けられる国へ】鈴木茉友
神戸常盤大学【はじめに】い。この理由から、未だに病院での言語問題への課題が解

近年、日本では外国人住民が増加している。さらに、こ決されていないのではないかと考える。そのため、在宅医れからも外国人住民が増加するということが示唆されて療では外来受け入れに比べて、より充実した診療を外国人いる。そんな中で、外国人が日本の医療に対して抱える問住民に対して行うことができるだろう。

題には、一番に言語の問題、次に病院選びである。また、病院側においても外国語への対応が未だに最も多い課題とされている。
この現状から、私は外国人住民が在宅医療を受けることができるようにすることで、この課題を解決できるのでは【病院選びの問題】
在宅医療で外国人住民の受け入れを可能にすることで、外国人住民が抱える言語問題だけでなく、病院選びの問題も解決できると考える。

ないかと考える。さらに臨床検査技師の参画やリモートの

私が考える案では、外国人住民から連絡を受けた自治体

導入を進め、在宅医療を今以上に充実化していきたい。こが臨床検査技師の派遣を病院へ要請する。そして、臨床検の論文では、これらについて詳しく述べていく。

査技師が在宅での検査結果をもとに、必要な診断、治療へ繋げる。この在宅医療のシステムにより、外国人の患者自【在宅医療へ臨床検査技師の参画】
現在、臨床検査技師の在宅医療への参画は少ないのが現状である。今の在宅医療の中心となっているのは、医師や身がどこの病院に行くべきなのかを考える必要が無くなる。したがって、外国人が在宅医療を受けることにより、病院選びの問題が解決できると考える。

看護師である。私は、この中に臨床検査技師も参画することで、より充実した在宅医療を提供できるのではないかと考える。

【終わりに】
在宅医療に臨床検査技師が今以上に参画し、外国人住民

臨床検査技師は、様々な検査データを総合的に考え、各の受け入れを考えていくことにより、充実した医療提供を患者のデータ推移や経過までも理解できる。また、採血な目指したい。また、リモートなどの現代発達しているテク

どの検体採取や処理から、正確な検査結果を出すことがでノロジーを在宅医療の現場でも用い、診療の効率化を図りきる。このようなことから、臨床検査技師は在宅医療に適たい。そして、医療を提供する側、受ける側どちらにも不した人材であると言えるだろう。そして、在宅医療の現場

自由のない医療現場にしていきたい。

において今以上に参画していくべきだと考える。

【リモートを用いた在宅医療】
コロナ禍により、私たちの働き方は大きく変化した。コロナ禍で、最も多く用いられたものとして、リモート（遠隔）が挙げられる。私は、このリモート化を在宅医療に用いることで、より患者に合わせた医療の提供を行えると考える。
臨床検査技師が出した正確な検査結果から、リモートを用いることにより、病院にいる医師や様々な医療従事者と円滑に連携を取ることができる。在宅医療を受ける患者に対しても、様々な医療職がチームとなり医療を提供することが、リモート化によりできるようになると考える。

【言語問題について】患者が行う申請情報から、事前に外国語対応の準備を行うことが可能である。これにより、検査や結果の説明を円滑に行うことができると考える。例えば、外国語での話し方や説明の仕方、イラストを用いた分かりやすい説明などを準備することができる。他には、文化の違いも事前に知ることができ、患者に合わせた医療提供ができると考える。
さらに、外国人患者も安心して診療を受けられると考えられる。
使用言語を知り事前準備を行うことは、外来の場合難し

連絡先：〒653-0838
兵庫県神戸市長田区大谷町 2 丁目 6-2
電話：078-611-1821
Fax:078-643-4361
学生氏名：鈴木茉友（スズキ マユ）
教員氏名：坂本秀生
教員電子メール：h-sakamoto@kobe-tokiwa.ac.jp

【What you can do as Biomedical Laboratory Scientists（BLS） to create a world
where you can receive equal medical care regardless of where you are born】
Anna Karashima
Yokkaichi Nursing and Medical Care University【Background】I want to create a world where
people all over the world can receive medical careequally. In developing countries, inadequate
medical care is killing young children. It waswhen I was in junior high school that I became
interested in medical care in developing
countries. In English class, I learned about theexperience of Dr. Nukdo Tomoko of MEDECINSSANS FRONTIERES. The last medical oxygen
cylinder was particularly impressive. A child wasbrought, but unfortunately it was too late. We
gave the child oxygen, but it did not get better.
And since that cylinder was her last one, shedecided to stop using it for someone in need. If
we had more medical equipment, we might havebeen able to give the best to the child. It's too
cruel to not be able to save lives that should havebeen saved because they were born in different
places.
【 Purpose 】 In the future, I would like toparticipate in the Japan Overseas Cooperation
Volunteers (JOCV) and contribute to theimprovement of medical care in developing
countries. I have an older sister who is a nurse,and she also wants to join the Japan Overseas
Cooperation Volunteers. You can hear from thenurse's older sister about her role as a nurse andher opinions. Additionally, as a Biomedical
Laboratory Scientist (BLS), I can share my roleand her views with her older sister. I would liketo collaborate with other professions to improve
the quality of medical care in developing
countries as well.
【Method】I suggest two methods. The first iswhat we can do as BLS to overcome the current
situation where young lives are lost in
developing countries. Infectious diseases such as
acquired
immunodeficiency
syndrome,
pneumonia, tuberculosis, and malaria arecommon causes of death in developing countries.
In developing countries, maternal mortality isalso high, including infectious diseases. Manycases could have been saved with appropriate
treatment, but due to the overwhelming
shortage of doctors, it is difficult to improve thecurrent situation. However, we believe that BLS
can prioritize patients by conducting tests. If so,
we believe we can save more lives with limited

equipment and personnel. In addition, in orderto prevent the spread of infectious diseases, we
propose to establish a system in which BLS
regularly conduct infectious disease tests. We
aim to improve the medical care itself indeveloping countries by training local BLS,
rather than just visiting and implementing them.
The second is a proposal for a solution tofinancial problems. My proposal requires a hugeamount of money. By using SNS such as
Instagram and Twitter and spreading apps, wehope to be able to communicate the current stateof medical disparities in an easy-to-understandmanner to young people like us. We think thatbuilding a system that leads to support not only
by donating, but also by liking, spreading theword, and watching videos will increase thenumber of people who are interested andcooperate with fundraising.
【Outlook】After obtaining a license as BLS, I
hope to gain more than three years of field
experience in Japan and participate in the Japan
Overseas Cooperation Volunteers in the future. I
want to contribute to the improvement of
medicalcareindeveloping
countries.
Furthermore, I would like to become a person
who can disseminate to the world the realities ofdeveloping countries that I have learned as BLS,
as well as think and implement measures toimprove the current situation. My big goal is tocreate a world where everyone can receive
medical care equally. In order to achieve that
goal, I am not good at English and I am nervous
about standing in front of people, but I wanted tochange myself, so I applied for this forum.
Through the student forum, I would like tointeract with many people, make connections,and take a step towards achieving my goals.
Contact information
Student name: Anna Karashima
Teacher name:Makiko Suzuki
Yokkaichi Nursing and Medical Care University
1200,Kayou-cho, Yokkaichi, Mie,512-8045,Japan
Tel: +81-340-0700
Fax:+81-361-1401
Teachers E-mail:m-suzuki@y-nm.ac.jp

【どこに生まれても平等な医療が受けられる世界にするために臨床検査技師としてできる事】
辛島杏奈
四日市看護医療大学【背景】私は世界中の人々が平等に医療を受けられる世界にしたいと思っている。発展途上国では十分な医療が行き届かず、幼い子供たちの命が失われている現状にある。私が発展途上国の医療について興味を持ったのは中学生の時である。英語の授業の中で「国境なき医師団」の存在を知ったのがきっかけである。
「国境なき医師団」とは 1971 年に設立した民間で非営利の医療・人道援助団体であり、紛争や自然災害、貧困などにより命の危機に瀕する人びとに医療を届けている。英語の授業で扱ったのは 1993 年に国境なき医師団に加わった
貫戸朋子博士の経験談である。その中で特に印象に残っているのが最後の酸素のボンベの話である。
明らかに手遅れの子供が運ばれてきた時に、酸素を吸入させたが良くならず、それが最後の酸素タンクだったため、酸素があれば救える人のためにボンベを止めると彼女は自身で決断したのだ。もしもっと医療機器が充実していたらその子供に最後まで最善を尽くすことができたし、もしかしたら助かっていたかもしれない。生まれた場所が違うだけで命の長さに大きな差が出てしまうのはあ
まりにも残酷である。
【目的】私は将来「青年海外協力隊」に参加し、発展途上国の医療の向上に貢献したい。私には看護師の姉がおり、同じように「青年海外協力隊」の参加を希望している。看護師の姉がいることで看護師の役割や意見を聞くことができ、さらに臨床検査技師としての役割や意見を姉に伝えることができるため、看護師と臨床検査技師との連携を考えて業務にあたることの重要性を感じている。他職
種とも連携しながら医療の質の向上を目指す。
【方法】 私は 2 つの方法を提案する。1 つ目は発展途上国で幼い命が奪われる現状を打開するために、臨床検査技師としてできる事である。発展途上国での死亡原因は、後天性免疫不全症候群、肺炎、結核、マラリアなどの感染症が多い。感染症の 95％
は発展途上国で起きている。また、5 歳未満の死亡数は、全体の半分近くまでに上り、5 歳未満の 3 大死亡原因においても、感染症が多くを占めている。
発展途上国では、妊婦の死亡率も高く、感染症も含まれる。適切な処置があれば助かったケースが多いことから、近年は医療従事者のもとで出産が行われるよう、積極的な働きかけが行われているが、圧倒的な医師不足により、改善することは難しい
現状にある。しかし、臨床検査技師が検査を実施することで、患者さんの優先順位を瞬時に見極めることで、限られた設備や人員でより多くの命を救うことができると考える。また、感染症の蔓延を防ぐために、臨床検査技師が定期的に感染症検査を実施するシステムを構築することを提案する。私たちが現地へ赴き実施するだけではなく、現地の臨床検査技師の育成をすることで、発展途上国の医療自体の向上を目指したい。
2 つ目は、金銭問題の解決策の提案である。私の提案には、莫大な費用が必要である。現在行われている取り組みとして、ユニセフの CM はとても効
果的だと感じている。募金によって支援できる制度を作っている組織はいくつかあるが、一つにまとめインスタや Twitter の SNS を利用すること
や、アプリを普及させることで、私たちのような若い世代にも医療格差の現状を分かりやすく発信でき、かつ気軽に支援できると考える。募金だけではなく、”いいね”や拡散、動画視聴をするだけで支援になるシステムを構築することでより興味を持つ人が増え、募金に協力する人たちが増えることにつながると考える。
【展望】私は臨床検査技師の資格取得後、日本での3 年以上の現場経験を積み、将来「青年海外協力隊」に参加し、発展途上国の医療の向上に貢献したい。
さらに、臨床検査技師として現場に立って知りえた発展途上国の実情をもっと世界に発信するとともに、この現状を改善するための対策を考え実行できる人間になりたい。この国際学生フォーラムの応募も、「誰もが平等に医療を受けることができる世界にしたい」という大きな目標のために、英語が苦手で、人前に立って発表することも緊張する
自分自身を変えたいという思いからである。強い思いを実現するために、行動力のある人になりたい。学生フォーラムを通し、多くの人と関わり、人脈を作り、自分の目標をかなえる一歩としたい。今回の応募をきっかけに、学生のうちに医療に関する幅広い知識や経験、人脈、行動力、対応力、アイディアなど、今の私にはないものをしっかりと身につけるため努力したい。
連絡先： 四日市看護医療大学〒512-8045 三重県四日市市萱生町 1200
電話：059-340-0705
Fax：059-361-1401
学生氏名：辛島杏奈(カラシマ アンナ)
教員氏名：鈴木真紀子(スズキ マキコ)
教員電子メール： m-suzuki@y-nm.ac.jp

72JAMT Young BLS Forum

WACE Facilitates Taiwan Laboratory Medicine to World Ace
What I would like to do internationally as a Biomedical Laboratory Scientist.
Name: Shih-Ching Huang
Advisor: Dr. Kang-Yi Su
Affiliation: 3rd Floor, No. 180, Section 1, Xinglong Road, Wenshan District, Taipei City
Abstract:
Laboratory medicine has an important role in clinical practice. All medical decisions including diagnostics,
treatments, monitoring, and outcome prediction should be based on testing results from medical laboratories,
so that physicians and payers can get precise, fast, helpful clinical reports. Not only the implementation ofquality systems in routine practice but also facing changes in the future of laboratory medicine, we should act
internationally as laboratory scientists.
Based on trends in laboratory medicine worldwide including efficient automation, collaborative sharing,
POCT (point-of-care test) diagnostics, and AI (artificial intelligence) application. I think “W-ACE” is a guidefor inspiring us to face challenges. W-ACE is “Wisdom”, “Accredited”, “Companion”, and “Evidence-based”
diagnostics. The goal of what I’d like to do is to create a wisdom healthcare diagnostic that everyone can besatisfied with testing results from not only in the hospitals, but also at home and in society for needs in therapy,
bring up care, and prevention. Moreover, Wisdom diagnosis can support health insurance and medical policy
for the government. Also, what we do must be matched by an accreditation system to make sure the reliabilityof results from LDTs (Lab Developed Tests), big data, and remote devices. Therefore, we can import more andmore LDTs or other new methods into our laboratories to satisfy more and more requests from the clinical.
Furthermore, companion diagnostics should be considered for clinical utility. Patients or users with testing
results can both benefit from treatment and avoid adverse side effects, also predict their regimens more
precisely. Therefore, evidence-based medicine can validate any test target in its clinical utilities.
Also, after doing “W-ACE”, there are still some issues we must dig into. First, when it comes to efficient
automation, although it can tackle manpower shortage and increase productivity, we need to solve “Safety”
issues in the automated testing process; Second, not all people nowadays are reliable on wisdom devices, thus,
we have to make our wisdom devices more acceptable to the public; Third, we have to make sure that our daily
health cares can not only have clinical utilities but also improve recipients’ life quality; Fourth, we have toensure that patients’ right and privacy would not be violated by our testing.
In conclusion, what would I like to do internationally as a biomedical laboratory scientist? I will identify
evidence-based test targets for companion diagnosis and combine big data with artificial intelligence to create
a wisdom future in laboratory medicine. Also, I will make sure the testing quality and polish accreditation
system nowadays for Laboratory medicine in Taiwan. After what I do, I hope Laboratory medicine in Taiwan
can be seen worldwide, and facilitate Laboratory medicine in Taiwan to World Ace.
Keywords: Wisdom, Accredited, Companion, Evidence-based, Laboratory medicine, healthcare

Developing an AI Model to Predict Pandemic
The AI model that can predict pandemics based on the big data of
infectious diseases occurring around the world
ShieHwang Ahn
Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University at
Wonju

Our clinical pathologist, as MT, is working with MD and other health care workers to conquer diseases
and social health of mankind. Clinical pathologists ar e in charge of quite a lot of tasks, from collecting
samples such as saliva, blood, and cerebrospinal fluid to each kind (various) tests, pathological tests, andphysiological functional tests. Among them, the growth of PCR and diagnosis has accelerated in relation
to COVID-19. In addition, as the world fights against COVID -19, the importance of preparing for the
new virus was greatly emphasized. During the COVID -19 pandemic, the number of big data and AI
modules developed far exceeds 100. Like this, we sho uld also concentrate on big data technology thatcan cope with new viruses. A whole new virus is not suddenly born. A new virus is the virus caused bymutation in the existing virus. Previously, countless viruses and their genetic information, even mutated
information were very big tasks until collecting and managing them. However, as technology advances,
technology that can handle big data has developed. Furthermore, AI will be used to predict the next
mutation and its probability. It will be much easier t o prepare for this, if we create a tool that can predict
pandemics based on the number of figures, reports and genetic information of infectious diseases
occurring around the world. I want to contribute to the management of infectious diseases around theworld by collaborating with big data experts or acquiring big data technology directly.

Formation of medical service network
What I Want To Do Internationally As A Medical Laboratory Technologist
Gyu ri Kim
AffiliaDaegu Haany University

With the influx of overseas infectious diseases such as MERS and COVID -19, the rapid againg of theworld, and the increase in chronic diseases, many changes have occurred in our lives. Due to this, thesocial need for Medical Laboratory Technologist, who are professional personal who provide essential
medical information for diagnosing diseases and determining treatment directions, continues to rise.
Therefore, I think that the existence of health care system that guarantees universal access will become
more important in the future, so I would like to suggest the improvement of various diseases using Big
Data and the strengthening POCT quality control . The biggest purpose of the improvement of various
diseases using Big Data and the strengthening POCT quality control is to establish diagnostic standards
for common diseases around the world, expand the health safety net, and provide reliable test results. In
order to prepare for this, we will continue to cultivate human resources tailored to the future medica lbusiness through continuous international cooperation and exchange activities with medicalorganizations and academic societies, and acquire international certifications such as ASCPi, IAC, RDCS,
RDMS, RA strengthen capacity and become a professional med ical person. Through this process, we
intend to carry out research on the improve common diseases around the world and strengthening POCT
quality control. Early diagnosis and prompt treatment are important for all diseases. In particular, cance r
and heart disease are diseases with high incidence worldwide and rank first and second as causes of death.
Therefore, in addition to IAC, RDCS, RDMS and RA certifications, we will collect information such as
various disease symptoms and mortality rates as various big data after acquiring the Big Data Expert Ce
rtification and conduct research to increase their early diagnosis rate. Big data refers to large-scale
formatted and atypical data characterized by enormous scale, fast delivery/analysis speed, and diverse
forms. The demand for big data is increasing for the purpose of using big data to create customer -centricbusiness outcomes and enhance various activities such as crisis management and problem solving. In fact,
there are several examples of the use of Big Data in the health care field. As the number of people withflu symptoms increases, the frequency of related vocabulary searches increases. Th erefore, Google has
set up an early warning system for the spread of influenza called 'GFT(Google Flu Trends)', which is amethod of forecasting influenza by displaying the frequency of influenza -related search terms by timeand region on a map. As another example, Seoul National University Bundang Hospital in South Korea
analyzes medical Big Data to support search and prevents inappropriate drug use in advance by providing
information related to drug safety in real time when prescribing and dispensing drug s. Just like this, aims
to contribute to the realization of improvement and alleviation of various diseases by combining Big
Data used in various ways with medical services and to provide more extensive and strengthened healthcare services through the for mation of national health care service networks based on medical knowledge
construction. POCT, which has been highlighted by COVID -19, is an on-site inspection and can performdisease diagnosis at the place where the patient is located without a separate e xamination room. In the
medical field, it is applied to the diagnosis of heart disease and infectious disease and is used in daily life
such as blood glucose meters, urine sticks, and COVID -19 self-test kits. POCT's strengths are that it is
rapid, inexpensive, has no location restrictions, and enables early diagnosis and rapid treatment.
Therefore, new POCT devices are being developed and put into practical use every year, but sensitivity
and accuracy are yet low. Quality Control is important for all inspec tions. However, there is no clear
regulation or guideline for POCT at present, and the reagents and equipment introduction decisionmethods are all different for each institution, which has the drawback of lowering sensitivity andaccuracy. Therefore, I be lieve that it is necessary to build a POCT system that can manage and operate
POCT more efficiently, improve POCT Quality Control, and improve the quality of inspections.
Therefore, standardize POCT test items, kits, cartridges, and reagents, steadily impl ement Quality
Control management, and educate non -professionals to maintain the reliability of test results. Improve
the safety, satisfaction, and reliability of the subjects by improving accuracy of the results such as
sensitivity and specificity of the test by supplementing these limitations by strengthening the quality of
POCT through the establishment of the POCT system and studying the diagnostic substances of various
diseases. Through the activation of POCT, I try to make diagnosis and treatment possi ble at a quick,sensitive, and low cost without restriction. After various diseases and the COVID-19 pandemic, interest
in and work for Medical Laboratory Technologist are becoming more important, but there are differencesin operating systems and job boundaries by country. Therefore, I think it is necessary to form a common
medical service network and become more professional medical personal in order to break down theseboundaries. This is expected to provide quality medical services, expand the health sa fety net, contribute
more to disease diagnosis and treatment, and provide more reliable test results.